Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.
Development of National Adaptation Strategy and Plan of Action for Health and Climate Change Related to the Main Arthropod-Borne Diseases in Iran
42 Pages Posted: 15 Nov 2019
More...Abstract
General Objective: To develop the National Adaptation Strategy and Plan of Action (NASPA) of I.R. Iran to manage adverse health impacts of arthropod-borne diseases related to climate change.
Methodology; four phases for implementation of project including comprehensive literature review of the existing studies and information on the subject of interest, involved development of vulnerability and adaptation assessment, review of existing documents, in-depth interview, focus group discussions and expert panels. Specification the conceptual and operational definition of adaptation for vector-borne disease health impact related to climate change, analysis of stakeholder with an actual impact or interest in vector-borne disease health management, determining the factors that had a potential effect on the vector-borne disease management of functions in climate change context, determine the objectives, policies, strategies and priority actions.
Results: Based on the vulnerable areas and the results of last national census in 2011, the vulnerable population for malaria will be about 14,000,000, the vulnerable population for leishmaniosis will be more than 30,000,000.
Discussion: If we consider the most climate sensitive vector-borne diseases of Iran, i.e. malaria and cutaneous leishmaniosis, that may affect more by climate change, then based on the climatology information and using Spline interpolation modeling.
Funding Statement: This research is founded by Department of Environmental Chemical Pollutants and Pesticides, Institute for Environmental Research, Tehran University of Medical Sciences,
Tehran, Iran.
Declaration of Interests: The authors declare that there is no conflict of Interest.
Ethics Approval Statement: This research is approved by the ethical section of Tehran University of Medical Sciences.
Keywords: Iran, vector borne, climate change
Suggested Citation: Suggested Citation